Study to Assess the Safety and Tolerability of PBF-1650 in Healthy Volunteers.
Status:
Completed
Trial end date:
2019-05-31
Target enrollment:
Participant gender:
Summary
Single center, randomized, double-blind, placebo-controlled clinical study to assess the
safety and tolerability of PBF-1650 in order to obtain the Maximum Tolerated Dose (MTD).